Mochi Health vs Noom
Mochi Health and Noom sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Mochi Health
Best for: coaching bundled into the price rather than sold separately
Visit Mochi Health →
If you are choosing between Mochi Health and Noom, price alone will not settle it. Noom leads our six-part score, 6.7 to 6.6.
Mochi Health vs Noom price
Noom publishes $199 a month. Mochi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Noom lists semaglutide and tirzepatide; Mochi Health does not name its drug.
On format, Mochi Health posts no priced format, while Noom prices brand-name pens and compounded injections.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
Mochi Health lists 15 states, and Noom does not publish where it ships.
Pricing
Mochi Health
Membership is $79/mo plus $60/mo for compounded semaglutide. The $39 membership Mochi leads with is a first-month rate for new customers; the standard rate is $79 per month after that. The $60 is a 'starting at' price that varies by dose, the lowest rung rather than a flat rate. $99 is shown struck through beside it.
Membership is $79/mo plus $90/mo for compounded tirzepatide. The $39 membership is a first-month promotional rate; the standard rate is $79. The $90 is a 'starting at' price that varies by dose. $199 is shown struck through beside it.
Noom
What each price covers
Both prices cover the clinician visit and coaching.
Mochi Health is silent on shipping and lab work.
Noom is silent on the medication itself, shipping and lab work.
Mochi Health
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Noom scores 6.7 and Mochi Health 6.6 out of 10.
Mochi Health is stronger on trust & safety (8.5 vs 6.5).
Noom is stronger on value (4.4 vs 3.0) and accessibility (5.0 vs 4.4).
Effectiveness, user experience and support are within half a point.
Mochi Health
6.6/10
Noom
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Mochi Health nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | Mochi Health | Noom |
|---|---|---|
| Starting Price | Not published | $199/mo |
| Features | ✓3 features | 2 features |
| States Available | 15 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Mochi Health
Mochi Health is an obesity medicine telehealth seller running aggressively priced compounded GLP-1 programs.
Read our full Mochi Health review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
Mochi Health
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Mochi Health
Watch-outs
- Not included in the monthly price: medication
- Serves only 15 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Noom wins this one, 6.7 to 6.6, above all for coaching bundled into the price rather than sold separately. Mochi Health fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Mochi Health if…
You want coaching bundled into the price rather than sold separately.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Mochi Health vs Noom: FAQ
Close alternatives to Mochi Health and Noom
- Mochi Health vs Embody
- Mochi Health vs TrimRx
- Mochi Health vs Henry Meds
- Mochi Health vs Hims
- Noom vs Hims
- Noom vs Hers
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.